Consistent with our findings, a 24-week randomized, placebo-controlled trial in adults at increased risk for dementia showed that anthocyanin supplementation reduced C-reactive protein, lowered LDL cholesterol, and improved a composite cardiometabolic score versus placebo, with larger CRP reductions among participants with higher baseline inflammation [61]. The gene discussed is CRP; the disease is dementia.